ScreenerHero

ONCOOnconetix Inc. Common Stock

NAS · US · Healthcare · Biotechnology · onconetix.com
0.6505USD-8.51%Mkt Cap: 2.57M $P/E: 0.00

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The compa…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$138.82BUSDP/E 31.9
REGN
Regeneron Pharmaceuticals, Inc.
$85.87BUSDP/E 20.5
ARGX
ARGENX SE
$61.34BUSDP/E 39.8
ARGX
argenx SE
$65.05BUSDP/E 39.6
MRNA
Moderna, Inc.
$57.94BUSD
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$44.89BUSD
ONC
BeOne Medicines AG
$42.36BUSDP/E 67.2
RPRX
Royalty Pharma Plc Class A
$35.43BUSDP/E 32.6
ALNY
Alnylam Pharmaceuticals, Inc.
$31.61BUSDP/E 41.2
BNTX
BioNTech SE
$29.28BUSD
INSM
Insmed Incorporated
$27.47BUSD
ROIV
Roivant Sciences Ltd. Common Shares
$26.22BUSD
INCY
Incyte Corporation
$25.91BUSDP/E 16.2
GMAB
Genmab A/S
$20.86BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$16.61BUSDP/E 19.6
JAZZ
Jazz Pharmaceuticals plc
$16.51BUSDP/E 17.4
BBIO
BridgeBio Pharma, Inc.
$15.93BUSD
EXEL
Exelixis, Inc.
$13.40BUSDP/E 17.0

Key Statistics

Company
Market Cap2.57M $
Enterprise Value-3.12M $
Revenue (TTM)645.82K $
Gross Profit632.91K $
Net Income (TTM)-14.03M $
Revenue/Share1.087 USD
Last Price0.6505 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.00
P/E (Forward)-0.78
PEG—
EV/EBITDA0.41
EV/Revenue-4.83
P/S4.08
P/B0.02
EPS (TTM)701.60
EPS (Forward)-0.85
52W Range
0.62070% of range209.50
52W High209.50 USD
52W Low0.6207 USD
Profitability
Gross Margin77.62%
Oper. Margin-13112.09%
EBITDA Margin0.00%
Profit Margin-1720.98%
ROE-89.00%
ROA-56.29%
Growth
Revenue Growth-83.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-9.68M $
CapEx (TTM)—
FCF Margin-921.26%
FCF Yield-231.61%
Net Debt-5.76M $
Net Debt/EBITDA0.75
Balance Sheet
Debt/Equity0.00
Current Ratio2.21
Quick Ratio2.02
Book Value/Sh42.63 USD
Cash/Share1.505 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMay 21, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.3.95M
Float3.95M
Insiders0.17%
Institutions7.33%
Short Interest
Short Ratio0.3d
Short % Float5.31%
Short % Out.5.31%
Shares Short196.17K
Short (prev mo.)61.62K
Technical
SMA 500.9125 (-28.7%)
SMA 20041.41 (-98.4%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)234.68K
Avg Vol (10d)223.61K
Technical Indicators
RSI (14)34.0
MACD-0.0958
MACD Signal-0.1029
MACD Hist.+0.0071
BB Upper0.9988 USD
BB Middle0.8317 USD
BB Lower0.6645 USD
BB Width40.20%
ATR (14)0.1098 USD
Vol Ratio (20d)1.19x